eMedevents
  • 130662+ Medical Conferences
  • 251 Specialties
  • 34291 Organizers
  • 147564 Speakers
  • 155 Countries
  • 4444 Cities
43554+
CME Conference Registrations Sold
Home  >  Conferences  >  Strategies to Maximize the Clinical Benefit of EGFR TKIs in Advanced NSCLC (May 2019)
CME : 2.00

Strategies to Maximize the Clinical Benefit of EGFR TKIs in Advanced NSCLC (May 2019)

May 31, 2019   |   Chicago, Illinois  United States of America
Specialties : Oncology
Conference Brochure

Strategies to Maximize the Clinical Benefit of EGFR TKIs in Advanced NSCLC (May 2019) is organized by Clinical Care Options (CCO), LLC and will be held on May 31, 2019 at Sheraton Grand Chicago, Chicago, Illinois, United States of America.

Target Audience:
This program is intended for physicians, oncology nurses, pharmacists, and other healthcare providers who care for patients with non-small-cell lung cancer.

Accreditation:
Physician Continuing Medical Education:

The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education:
The maximum number of hours awarded for this Continuing Nursing Education activity is 2.0 contact hours.

Pharmacist Continuing Education:
Credit Designation:

Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education.

Goal Statement:
The goal of this activity is to improve participants’ knowledge of and competence in applying EGFR inhibitors in the treatment of patients with EGFR-mutated non-small-cell lung cancer.

Learning Objectives:
• Apply expert recommendations for frontline therapy for advanced EGFR-mutated NSCLC focusing on safety, efficacy, and the individualization of therapy based on tumor-specific and patient-specific factors
• Compare the efficacy and safety of first-generation EGFR TKIs with later-generation EGFR TKIs
• Examine current recommendations for molecular testing and the roles for liquid biopsies in guiding the use of EGFR TKI therapy
• Plan optimal sequencing of EGFR TKIs after considering the available evidence and expert recommendations
• Evaluate current and evolving treatment approaches to address acquired resistance and progression in advanced EGFR-mutated NSCLC

Attending

Brandon Alyas
Brandon Alyas

Family Medicine

Tracking

Brandon Alyas
Brandon Alyas

Family Medicine

Registration Desk

Contact No. : 1-855-224-2241
Email:
HR@clinicaloptions.com

Conference Fee Details

Conference Fee : Free
Early Fee : NA
Early Fee Last date : NA

  • Drive Walk Transit Bicycle

Venue Address

Sheraton Grand Chicago
Chicago Ballroom, 6 (Ballroom Level), 301 E North Water St
Chicago, Illinois, United States of America

Plan Your Travel

 
 
 
 

Please Rate this Conference

 0.0
 0.0
 0.0
 0.0
 0.0

Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

Hotel Zachary, Chicago, A Tribute Portfolio Hotel
4.48 miles from venue
Price : USD 199.00 Per Night
The Wheelhouse Hotel
4.3 miles from venue
Price : USD 118.00 Per Night
The Hotel At Midtown
4 miles from venue
Price : USD 189.00 Per Night
The Robey
3.36 miles from venue
Price : USD 295.00 Per Night
Close

Session Details

Session Topic Start Time End Time Location Description Speakers
Close

Workshop Details

Title Start Time End Time Workshop Fee

Subscribe to our Newsletter

x

Subscribe to our newsletter and receive updates on medical conferences, board review courses and news